Form 4: Allurion Technologies CEO Granted Stock Options
SEC Form 4 Filing
Allurion Technologies' CEO, Shantanu Gaur, was granted stock options to purchase 1,298,701 shares of common stock on May 3, 2024.
Summary
- Shantanu Gaur, CEO of Allurion Technologies, Inc., was granted stock options on May 3, 2024.
- The options allow him to purchase 1,298,701 shares of Allurion Technologies common stock at an exercise price of $2.30 per share.
- 25% of the shares underlying the option vest on May 3, 2025, with the remaining shares vesting in 36 equal monthly installments thereafter, contingent upon continued service.
Sentiment
Score: 6
Explanation: The document is neutral in tone, simply reporting the granting of stock options. It's a standard corporate action, and the sentiment is moderately positive as it incentivizes the CEO.
Positives
- The granting of stock options to the CEO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedule encourages long-term commitment from the CEO.
Risks
- The value of the stock options is dependent on the future performance of Allurion Technologies' stock price.
- If the CEO leaves the company before the options fully vest, a portion of the options may be forfeited.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.
Industry Context
Stock options are a common form of executive compensation in the technology industry, used to attract and retain talent and align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages, particularly in growth-oriented companies like Allurion Technologies.
- Comparable companies often use similar vesting schedules to incentivize long-term performance and retention.
- The size of the grant is likely determined by a number of factors including the executive's role, company performance, and industry benchmarks.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it aligns the CEO's interests with theirs.
- Employees may see it as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of the stock option grant. |
| 05/03/2025 | 25% of the shares underlying the option vest. |
| 05/02/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.